supplemental figure 3

02 05 07 08 10 12 01 03 04 06 09 11 0 5 10 15 20 25 estimated baseline rate (2003) hospitals (1-12) thrombolysis percentage (%) control hospitals intervention hospitals

Upload: quinn-tran

Post on 31-Dec-2015

20 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

DESCRIPTION

- PowerPoint PPT Presentation

TRANSCRIPT

02 05 07 08 10 12 01 03 04 06 09 110

25 estimated baseline rate (2003)rate in the study

hospitals (1-12)

thro

mboly

sis

per

centa

(%)

control hospitals intervention hospitals

Supplement Supplemental Figures and Supplemental Figure

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure Legends

Figure I supplemental

Supplemental materials 2 Supplemental Figure 1.Antibody ...dm5migu4zj3pb.cloudfront.net/manuscripts/66000/66824/JCI66824sd.pdf · Supplemental Figure . PRL5 -3 is expressed at higher

Supplemental Figure 1

Supplemental Digital Content Supplemental Figure 1

Supplemental Information Recruitment of UBPY and ESCRT ...Supplemental Movie 2, related to Figure 1(available online) Supplemental Movie 3, related to Figure 1(available online) Supplemental

Hull et. al. 2015. 43 · Hull et. al. 2015. 43 SUPPLEMENTAL FIGURE LEGENDS: Supplemental Figure 1: Western blots used to generate the densitometry values depicted in Figure 3. Supplemental

Supplemental Figure 2 - Genes & Developmentgenesdev.cshlp.org/.../gad.269118.115.DC1/SuppFigure_3.pdf2015/09/22 · Santaguida_Supplemental Figure 3 Title Supplemental Figure 2 Created

Supplemental Figure 3

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B

Supplemental Figure 2 - Cancer Discovery · SUPPLEMENTAL FIGURE 2. Title: Supplemental Figure 2 Created Date: 7/29/2016 10:43:37 AM

Supplemental Figure Legends: Supplemental Figure 1 ...dm5migu4zj3pb.cloudfront.net/manuscripts/59000/59743/JCI...31 Supplemental Figure Legends: Supplemental Figure 1. Caerulein treatment

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Tables and Supplemental Figure Legends...2014/04/14 · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Figure 1 (related to Figure 1) · Supplemental Figure 1 (related to Figure 1) Styrofoam Stimulus Coverslip Clay Acrylic platform Insect pin scaffold B E 0.45 3 PHDQ ¨

Supplemental Figure 1 · 2011-10-21 · Supplemental Figure 3 CTL TCDD (20 nM) MCDF (5 M) MCDF (5 M) + SOX4 TCDD (20 nM) + SOX4 CTL + SOX4 Supplemental Figure 3. MDA-MB-231 cell invasion

Supplemental data: Supplemental Figure 1. Sequence of

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Supplemental figure 2

Supplemental Figure 1

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Collected Supplemental Figures Marginsgenesdev.cshlp.org/content/suppl/2007/10/01/21.19.2448.DC1/... · Supplemental Figure 2 Supplemental Figure 4 Supplemental Figure 5 Supplemental

Supplemental Figures S1-S8. Supplemental Figure S1

Supplemental Figure S1

SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell ...genesdev.cshlp.org/.../Supplemental_Figures.pdf · 6.02.2017 · SUPPLEMENTAL FIGURE LEGENDS Figure S1. Programmed cell

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure 3, Ghielmetti et al

Figure Legends for Supplemental Figures Supplemental

Supplemental Figures · Web viewSupplemental Appendix Supplemental Figures2 Figure S1: Patient disposition2 Figure S2: Cytokine-related TEAEs of interest by cycle (N=38)3 Figure S3:

Supplemental Figure 1

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures